JPRN-UMIN000002490Recruiting未知
Pharmacogenetic analysis to investigate the association between efficacy and neurotoxicity of oxaliplatin and single nucleotide polymorphisms - Pharmacogenetic analysis of oxaliplatin
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Kyoto University Hospital
- Enrollment
- 133
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The patients with a history of adjuvant chemotherapy using oxaliplatin
Investigators
Similar Trials
Active, not recruiting
Not Applicable
A retrospective pharmacogenetic analysis of patients with elevated liver enzymes (Hy s law cases or AST/ALT > 10x ULN) in clinical studies CCOX189A0117, CCOX189A2332, CCOX189A2369, CCOX189A0126, CCOX189A0112, CCOX189A0109 or CCOX189A2361 - NDpatients with elevated liver enzymes (Hy s law cases or AST/ALT > 10xEUCTR2009-017148-15-ITOVARTIS FARMA37
Completed
Not Applicable
Patient Controlled Analgesia Pharmacogenetic StudyPainNCT01731873Children's Hospital Medical Center, Cincinnati182
Completed
Not Applicable
Clinical pharmacology and pharmacogenetic study on the clinical response for tamoxifeBreast cancerJPRN-UMIN000001411Saitama Medical University, Saitama International Medical Center100
Recruiting
Not Applicable
A pharmacogenomics study for adverse effects and clinical outcome to S-1 in gastric cancer patientsgastric cancerJPRN-UMIN000004968Department of Clinical Pharmacology and Genitics, School of Pharmaceutical Science, Univercity of Shizuoka100
Active, not recruiting
Not Applicable
APPLICATION OF PHARMACOGENOMICS IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER - PHARMACOGENOMICS IN THE ELDERLYELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCERMedDRA version: 6.1Level: HLTClassification code 10010040EUCTR2006-004016-40-ITAZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI